126 related articles for article (PubMed ID: 16855006)
21. Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III.
Pelleymounter MA; Joppa M; Ling N; Foster AC
Peptides; 2004 Apr; 25(4):659-66. PubMed ID: 15165722
[TBL] [Abstract][Full Text] [Related]
22. Corticotropin-releasing factor receptor subtypes mediating nutritional suppression of estrous behavior in Syrian hamsters.
Seymour PL; Dettloff SL; Jones JE; Wade GN
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R418-R423. PubMed ID: 15831766
[TBL] [Abstract][Full Text] [Related]
23. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155
[TBL] [Abstract][Full Text] [Related]
24. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
Maillot C; Million M; Wei JY; Gauthier A; Taché Y
Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
[TBL] [Abstract][Full Text] [Related]
25. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
26. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
Miguel TT; Nunes-de-Souza RL
Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
[TBL] [Abstract][Full Text] [Related]
27. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
Staub DR; Evans AK; Lowry CA
Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
[TBL] [Abstract][Full Text] [Related]
28. Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain.
Yoneda M; Nakamura K; Nakade Y; Tamano M; Kono T; Watanobe H; Shimada T; Hiraishi H; Terano A
Gut; 2005 Feb; 54(2):282-8. PubMed ID: 15647195
[TBL] [Abstract][Full Text] [Related]
29. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
Bagosi Z; Jászberényi M; Szabó G; Telegdy G
Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090
[TBL] [Abstract][Full Text] [Related]
30. Increase of core temperature induced by corticotropin-releasing factor and urocortin: a comparative study.
Figueiredo MJ; Fabricio AS; Machado RR; Melo MC; Soares DM; Souza GE
Regul Pept; 2010 Dec; 165(2-3):191-9. PubMed ID: 20691217
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
Pelleymounter MA; Joppa M; Ling N; Foster AC
J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
[TBL] [Abstract][Full Text] [Related]
32. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
33. Peripheral urocortin delays gastric emptying: role of CRF receptor 2.
Nozu T; Martinez V; Rivier J; Taché Y
Am J Physiol; 1999 Apr; 276(4):G867-74. PubMed ID: 10198329
[TBL] [Abstract][Full Text] [Related]
34. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
Turnbull AV; Vale W; Rivier C
Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
[TBL] [Abstract][Full Text] [Related]
35. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
37. Peripheral corticotropin-releasing factor (CRF) induces stimulation of gastric contractions in freely moving conscious rats: role of CRF receptor types 1 and 2.
Nozu T; Tsuchiya Y; Kumei S; Takakusaki K; Okumura T
Neurogastroenterol Motil; 2013 Feb; 25(2):190-7. PubMed ID: 23205497
[TBL] [Abstract][Full Text] [Related]
38. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
Rivier J; Gulyas J; Kirby D; Low W; Perrin MH; Kunitake K; DiGruccio M; Vaughan J; Reubi JC; Waser B; Koerber SC; Martinez V; Wang L; Taché Y; Vale W
J Med Chem; 2002 Oct; 45(21):4737-47. PubMed ID: 12361401
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing factor potentiates the contractile response of rabbit airway smooth muscle to electrical field stimulation but not to acetylcholine.
Tamaoki J; Sakai N; Kobayashi K; Kanemura T; Shibasaki T; Takizawa T
Am Rev Respir Dis; 1989 Nov; 140(5):1331-5. PubMed ID: 2817596
[TBL] [Abstract][Full Text] [Related]
40. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
